B.
Capsule formation was examined in wild type and metallothionein mutants. Cells were incubated in RPMI medium supplemented with serum at 37°C, 5% CO 2 for 3 days to induced capsule formation. Capsule structure was stained with India ink, visualized by a Zeiss Axio microscope and photographed.
C. Capsule thickness of C. neoformans wild type and metallothionein mutants was measured and normalized to that of wild type. Photographs from (B) were taken and 60 cells for each strain were measured for capsule thickness. Statistical analysis was performed using the student t test. Error bars indicate standard deviation.
D.
Phagocytic index was evaluated using bone marrow derived macrophages. Bone marrow cells were isolated from 6 to 8 week old female A/J mice, and differentiated to primary macrophage by GM-CSF at 37°C, 5% CO 2 for 5 days.
Before phagocytosis assay, primary macrophages were activated with interferon-γ (5 ng/ml) and lipopolysaccharide (1 µg/ml) for 1 hr. Overnight cultures of wild type and cmt1∆ cmt2∆ cells were washed three times with PBS, and incubated with activated BMDM for 3 hrs. Extracellular fungal cells were eliminated by washing 5 times with PBS. The phagocytic index was calculated as previously described (Sano et al., 2003) . Cells were visualized and macrophage and internalized fungal cells were counted. The graph represents an average of four replicates; over 200 macrophages were counted for each replicate. The phagocytic index was calculated and normalized to that from wild type. Statistical analysis was performed using the student t test. Error bars indicate standard deviation. Two metallothioneins from each organism were aligned using Clustal W (Larkin et al., 2007) . Alignment results are shaded using boxshade (http://www.ch.embnet.org/software/BOX_form.html). Table S1 A. Quantitative RT-PCR was performed to confirm expression of the CMT1 alanine mutant in C. neoformans. Cells were cultured at an initial A 600 of 0.2 for 3 hrs in SC medium at 37°C. 100 μM BCS or 100 μM Cu was then added and cultures incubated for 1 hr, since the cmt1∆ cmt2∆ strain is Cu sensitive. cDNA was synthesized, and qRT-PCR was performed as previously described (Ding et al., 2011) , using primers TACGAGCGAGGCTCAAGACA and CAGGCAGCGCCAGATCCGCT, which recognize both wild type and alanine mutated CMT1. Relative expression levels were normalized to ACT1. Statistical analysis was performed using student t test. Error bars indicate standard deviation. 
B. Deconvoluted ESI-MS

Supplemental Experimental Procedures
Generation of Cryptococcus Mutants and Biolistic Transformation
Cryptococcus Metallothionein (CMT) complementation strains were generated as follows: CMT1 and CMT2 genomic DNA was amplified and cloned into the pHYG7-KB1
plasmid (a gift from Dr. Jennifer Lodge, Washington University) (Hua et al., 2000) . The resulting plasmids were transformed using biolistic methods as previously described (Toffaletti et al., 1993) . The CMT1ala DNA sequence was synthesized by IDT (Integrated DNA Technologies) with mutation of all cysteine codons to alanine codons.
The CMT1ala sequence was amplified using primer pair MT1alaKpnI/ClaI (GGGGGGTACCATGGCTGCAAACGCACCTCCC/GGGGATCGATTCAGGCAGCGCC AGATCCGCT), digested with KpnI and ClaI, and cloned into a pMT1 plasmid (which is a CMT1 expression plasmid with KpnI and ClaI between CMT1 promoter and terminator sequences).
The luciferase gene was amplified using primer pair LucCTR4F/R for CTR4 promoter (TTTACGAAAGGACACCATCCATCATGGAAGATGCCAAAAACATT/CATCCGGTACA TATTATTACTCTTTTACACGGCGATCTTGCCGCCC) or LucMT1F/R for CMT1 promoter (CAACTCAAACAAACTACAATCATGGAAGATGCCAAAAACATT/AGCATTGGTCTGG AAGACAAGCTTACACGGCGATCTTGCCGCCC). CTR4-Luciferase was generated using the CTR4 promoter, terminator and luciferase gene in an overlapping PCR, whereas the CTR4 promoter was amplified using primer pair CTR4promoterF/R (GGGGTCTAGATGGATGGTATTCTTCAGTTCCGT/GATGGATGGTGTCCTTTCGTAA A) and the CnCTR4 terminator was amplified using primer pair CTR4terminatorF/R (AAGAGTAATAATATGTACCGGATG/GGGGTCTAGAAGCCTCTGCGACGTTACCGAT CA). CMT1-Luciferase was generated as described for CTR4-Luc using primer pair (GGGGTCTAGATAATCGCTCTCTCGGAGGAA/GATTGTAGTTTGTTTGAGTTG) for CMT1 promoter, and primer pair GCTTGTCTTCCAGACCAATGCT/GGGGTCTAGAGGAATGTGTATCAAAACTTGGG) for CMT1 terminator. The resulting overlapping PCR fragments were cloned into the pHYG7-KB1 plasmid. The plasmid was transformed into Cryptococcus by biolistic transformation (Toffaletti et al., 1993) .
The pHYG-Cuf1-2xFLAG was cloned using the following strategy. PCR products were digested with NotI/XbaI and XbaI/NheI respectively. Vector pHYG7-KB1 was digested with NotI/SpeI (SpeI and NheI have compatible overhangs). A triple ligation was performed and transformed into E. coli strain DH5 to obtain the vector pHYG-Cuf1-2xFLAG, which was confirmed and biolistically transformed into the cuf1 strain and resulting transformants were validated and tested for growth on 1 mM CuSO 4 and 1 mM BCS.
Chromatin Immunoprecipitation
The following primers were used to amplify approximately 300 bp of their respective 
Metallothionein Expression, Synthesis, and Purification
The CMT1ala sequence (Cmt1 cysteine to alanine) was synthesized by Integrated DNA Technologies. The cDNA sequence from CMT1 or CMT2 or synthetic DNA sequence from CMT1ala was cloned in a pGEX-4T1 expression vector (GE Healthcare). The recombinant plasmids were transformed into the E. coli MachI strain for sequence determination. Positive clones were transformed into the E. coli BL21 protease deficient strain for protein synthesis. optimize intracellular Cu availability (Pagani et al., 2007) . The total protein extract was prepared from bacterial cultures as previously described (Capdevila et al., 1997) . In vivo-folded metal-Cmt complexes were recovered from the Cmt-GST fusion constructs by thrombin cleavage and batch-affinity chromatography using Glutathione-Sepharose 4B (GE Healthcare). After concentration using Centriprep Microcon 3 (Amicon), samples were purified through FPLC in a Superdex75 column (GE Healthcare) equilibrated with 50 mM Tris-HCl, pH 7.0. Selected fractions were confirmed by 12%
SDS-PAGE and kept at -80 o C until further use. All procedures were performed using Ar (pure grade 5.6) saturated buffers, and all syntheses were performed at least twice to ensure reproducibility, as described previously (Capdevila et al., 1997) . As a consequence of the cloning requirements, a dipeptide Gly-Ser or penta-peptide Gly-SerPro-Glu-Phe were present at the amino terminus of Cmt1 or Cmt2, respectively; but this had previously been shown not to alter the MT metal-binding features. In vitrosubstituted Cu(I)-MT complexes were obtained by titration of the Zn(II)-MT preparations with Cu(I) at pH 7, using [Cu(CH 3 CN) 4 ]ClO 4 solutions, as previously described (Bofill et al., 1999) . During all experiments strict oxygen-free conditions were maintained by saturating all the solutions with Ar.
